CALC CalciMedica Inc. Common Stock

USD 4.01 -0.12 -2.905569
Icon

CalciMedica Inc. Common Stock (CALC) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 4.01

-0.12 (-2.91)%

USD 0.05B

0.03M

USD 17.86(+345.32%)

USD 4.00 (-0.25%)

Icon

CALC

CalciMedica Inc. Common Stock (USD)
COMMON STOCK | NSD
USD 4.01
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.05B

USD 4.00 (-0.25%)

USD 4.01

CalciMedica Inc. Common Stock (CALC) Stock Forecast

Show ratings and price targets of :
USD 17.86
(+345.32%)

Based on the CalciMedica Inc. Common Stock stock forecast from 3 analysts, the average analyst target price for CalciMedica Inc. Common Stock is USD 17.86 over the next 12 months. CalciMedica Inc. Common Stock’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of CalciMedica Inc. Common Stock is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, CalciMedica Inc. Common Stock’s stock price was USD 4.01. CalciMedica Inc. Common Stock’s stock price has changed by -16.63% over the past week, -25.05% over the past month and +8.09% over the last year.

No recent analyst target price found for CalciMedica Inc. Common Stock
No recent average analyst rating found for CalciMedica Inc. Common Stock

Company Overview CalciMedica Inc. Common Stock

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small mole...Read More

https://www.calcimedica.com

505 Coast Boulevard South, La Jolla, CA, United States, 92037

13

December

USD

USA

Adjusted Closing Price for CalciMedica Inc. Common Stock (CALC)

Loading...

Unadjusted Closing Price for CalciMedica Inc. Common Stock (CALC)

Loading...

Share Trading Volume for CalciMedica Inc. Common Stock Shares

Loading...

Compare Performance of CalciMedica Inc. Common Stock Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CALC

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To CalciMedica Inc. Common Stock (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +4.34 (+0.88%) USD126.85B 31.94 20.00

ETFs Containing CALC

Symbol Name CALC's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About CalciMedica Inc. Common Stock (CALC) Stock

Based on ratings from 3 analysts CalciMedica Inc. Common Stock's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 7 buy, sell and hold ratings.

Unfortunately we do not have enough data on CALC's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for CALC is USD 17.86 over the next 12 months. The maximum analyst target price is USD 22 while the minimum anlayst target price is USD 14.

CALC stock's Price/Earning ratio is 0.30. Our analysis grades CALC stock's Price / Earning ratio at B-. This means that CALC stock's Price/Earning ratio is above 20% of the stocks in the Biotechnology sector in the NSD exchange. Based on this CALC may be undervalued for its sector.

The last closing price of CALC's stock was USD 4.01.

The most recent market capitalization for CALC is USD 0.05B.

Based on targets from 3 analysts, the average taret price for CALC is projected at USD 17.86 over the next 12 months. This means that CALC's stock price may go up by +345.32% over the next 12 months.

We can't find any ETFs which contains CalciMedica Inc. Common Stock's stock.

As per our most recent records CalciMedica Inc. Common Stock has 13 Employees.

CalciMedica Inc. Common Stock's registered address is 505 Coast Boulevard South, La Jolla, CA, United States, 92037. You can get more information about it from CalciMedica Inc. Common Stock's website at https://www.calcimedica.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...